Abstract
Abstract
Purpose
Improved health outcomes for individuals ever diagnosed with cancer require comprehensive, coordinated care that addresses their supportive care needs. Implementing interventions to address these is confounded by a lack of evidence on population needs and a large pool of potential interventions. This systematic review estimates the point prevalence of different supportive care needs stratified by the tool used to measure needs and cancer type in Australia.
Methods
We searched MEDLINE, Embase, and Scopus from 2010 to April 2023 to identify relevant studies published on the prevalence of supportive care needs in Australia.
Results
We identified 35 studies that met the inclusion criteria. The highest prevalent unmet need across all cancers was ‘fear of cancer spreading’ (20.7%) from the Supportive Care Needs Survey Short-Form 34 (SCNS-SF34), ranging from 9.4% for individuals ever diagnosed with haematological cancer to 36.3% for individuals ever diagnosed with gynaecological cancer, and ‘concerns about cancer coming back’ (17.9%) from the Cancer Survivors’ Unmet Needs (CaSUN), ranging from 9.7% for individuals ever diagnosed with prostate cancer to 37.8% for individuals ever diagnosed with breast cancer. Two studies assessed needs in Aboriginal and Torres Strait Islander populations, reporting the highest needs for financial worries (21.1%).
Conclusions
Point prevalence estimates presented here, combined with estimates of the costs and effects of potential interventions, can be used within economic evaluations to inform evidence-based local service provision to address the supportive care needs of individuals ever diagnosed with cancer.
Implications for Cancer Survivors
Local health services can use local evidence to prioritise the implementation of interventions targeted at unmet needs.
Publisher
Springer Science and Business Media LLC
Reference69 articles.
1. Kocarnik JM, Compton K, Dean FE, Fu W, Gaw BL, Harvey JD et al (2022) Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis for the Global Burden of Disease Study 2019. JAMA oncology 8(3):420–444
2. Australian Institute of Health and Welfare (2021) Cancer in Australia 2021. Cancer series no 133 Cat no CAN 144. AIHW, Canberra
3. Global Burden of Disease Cancer Collaboration (2019) Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: a systematic analysis for the global burden of disease study. JAMA oncology
4. Schiffman JD, Fisher PG, Gibbs P (2015) Early detection of cancer: past, present, and future. American Society of Clinical Oncology Educational Book 35(1):57–65
5. Jackson SE, Chester JD (2015) Personalised cancer medicine. Int J Cancer 137(2):262–266